Physician profile
Mark J Foreman
NPI 1467656272
$1,445.54
in general payments reported to CMS, 2019-2025
17 companies · $260 in 2025
The $260 reported for 2025 was more than what 81% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2020: $249 · 2021: $236 · 2022: $78.73 · 2023: $89.40 · 2024: $331 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $400.79 | 2023-2025 | Na, Va-Lcp, Hammerlock |
| Janssen Pharmaceuticals, INC | $152.24 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $140.21 | 2020-2024 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $137.87 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.72 | 2020-2025 | Jardiance |
| Novo Nordisk INC | $101.52 | 2019-2025 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $78.91 | 2020-2025 | Zerbaxa, Dificid, Recarbrio |
| Mylan Specialty L.P. | $49.85 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $45.82 | 2024-2025 | |
| Alexion Pharmaceuticals, INC. | $38.57 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $38.20 | 2020-2021 | |
| Abbvie INC. | $30.88 | 2024 | |
| Boston Scientific Corporation | $27.30 | 2021 | |
| Portola Pharmaceuticals, LLC | $24.98 | 2020 | |
| Pfizer INC. | $23.15 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $19.49 | 2020 | |
| Medtronic, INC. | $19.04 | 2023 | Linq II |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Foreman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.